Skip to content
Menu

Mesa Laboratories, Inc. MLAB

Full chart Compare
Set alert

Price alert · MLAB

All alert types
133.41 USD -4.40 (-3.19%)

Regular-session close

133.41 0.00 0.00%

After hours · Nov 19, 4:01 PM ET

132.99 Day range 140.29
70.19 52-week range 144.35
YTD
+69.95%
1 year
+88.65%

 

No chart data for this range yet.
Market cap
749.83M
Revenue (ttm)
228.38M
Profit margin
-107.56%
EPS (ttm)
1.12
Shares out
5.43M
P/E ratio
119.12
Forward P/E
18.42
Dividend
0.64 (0.48%)
Ex-dividend date
Nov 29, 2024
YTD return
+69.95%
1-year return
+88.65%
Volume
101.74K
Avg volume
117.63K
Open
140.29
Previous close
137.81
Day's range
132.99 – 140.29
52-week range
70.19 – 144.35
Beta
0.86
Price target
133.33 (-0.1%)
50-day average
120.63
200-day average
113.75
Enterprise value
914.23M

Key statistics

Price / sales
3.22
Price / book
4.55
Payout ratio
376.47%
Revenue growth
8.80%
Free cash flow
48.73M
Total cash
26.00M
Total debt
222.86M
Return on equity
-89.46%
Short % of float
3.97%

Fundamental scorecard

15 of 25 checks passed on MLAB’s reported financials

ValueGrowthProfitabilityHealthDividend

15of 25 checks passed

  • Value 2 of 5
  • Growth 4 of 5
  • Profitability 3 of 5
  • Financial health 2 of 5
  • Dividend 4 of 5

Statements to Sep 30, 2026.

Financials — quick view

All financials
MLAB Revenue — quarterly 62.34M
MLAB Net income — quarterly 4.34M
MLAB EPS — quarterly 0.77

Earnings

MLAB recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 3, 2025Dec 1, 20242.45———
Nov 7, 2024Sep 1, 20242.482.45-0.03-1.21%
Aug 5, 2024Jun 1, 20242.332.83+0.50+21.46%
Feb 5, 2024Dec 1, 20232.042.02-0.02-0.98%
Nov 6, 2023Sep 1, 20231.651.91+0.26+15.76%
Aug 3, 2023Jun 1, 20231.671.77+0.10+5.99%

Upgrades / downgrades

MLAB analyst upgrades and downgrades
DateFirmActionFromTo
Oct 1, 2024Evercore ISI GroupmainOutperformOutperform
Aug 27, 2024Wells Fargoinit—Underweight
Aug 6, 2024Evercore ISI GroupmainOutperformOutperform
Jul 2, 2024Evercore ISI GroupmainOutperformOutperform
Apr 4, 2024Evercore ISI GroupmainOutperformOutperform
Jan 4, 2024Evercore ISI GroupupIn-LineOutperform

About Mesa Laboratories, Inc.

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. The Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. The Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems, offered under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.

Sector
Technology
Industry
Scientific & Technical Instruments
Country
United States
Website
mesalabs.com

News

Your note

Sign in to keep a note on MLAB — it syncs with the Stock Master app.

Insider holders

MLAB insider holders
InsiderRelationLatest transactionDateShares held
ALLTOFT JENNIFER SADIEDirectorConversion of Exercise of derivative securityAug 29, 20243,474
ARCHBOLD BRIAN DAVIDOfficerSaleSep 12, 20240
CAPONE MARK CHRISTOPHERDirectorConversion of Exercise of derivative securityAug 14, 2024724
HALL SHANNONDirectorConversion of Exercise of derivative securityAug 29, 20242,785
LADIWALA SHIRAZ SHABANALIDirectorConversion of Exercise of derivative securityAug 29, 20243,074
OWENS GARY MChief Executive OfficerSaleOct 28, 202443,337

Institution ownership

MLAB institution ownership
Holder% heldSharesValueReported
Blackrock Inc.15.41%836,821113.31MSep 29, 2024
Conestoga Capital Advisors, LLC9.74%529,11071.64MSep 29, 2024
Vanguard Group Inc6.95%377,58251.12MSep 29, 2024
Royce & Associates LP6.39%347,14547.00MSep 29, 2024
Morgan Stanley4.59%249,34833.76MSep 29, 2024
Ranger Investment Management, L.p.4.39%238,19032.25MSep 29, 2024

Fund ownership

MLAB fund ownership
Holder% heldSharesValueReported
Conestoga Small Cap Fund6.70%363,98549.28MSep 29, 2024
iShares Core S&P Smallcap ETF6.33%343,77046.55MOct 30, 2024
Vanguard Total Stock Market Index Fund2.94%159,57121.61MSep 29, 2024
iShares Russell 2000 ETF2.43%131,94517.87MOct 30, 2024
Royce Small-Cap Fund1.92%104,55014.16MSep 29, 2024
Royce Micro Cap Trust1.92%104,13214.10MSep 29, 2024